Russian Association of Endocrinologists reports commencement of Trajenta clinical use

QR Code

Russian Association of Endocrinologists reports commencement of Trajenta clinical use

Enregistré dans:

Détails bibliographiques
Auteur principal:	Editorial team Diabetes Mellitus
Format:	article
Langue:	EN RU
Publié:	Endocrinology Research Centre 2012
Sujets:	russian association of endocrinologists diabetes mellitus dpp-4 inhibitor linagliptin trajenta Nutritional diseases. Deficiency diseases RC620-627
Accès en ligne:	https://doaj.org/article/fbeca3c5dbc146cc9c935f247bbc1bb4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Expert committee on novel DPP-4 inhibitor TRADJENTA (linagliptin) in treatment of type 2 diabetes mellitus
par: Editorial team Diabetes Mellitus
Publié: (2012)

Biopharmaceuticals. Official position of Russian Association of Endocrinologists
par: Editorial team Diabetes Mellitus
Publié: (2013)

Russian Association of Endocrinologists about the introduction of Diabeton MR (60 mg tablets)
par: Editorial team Diabetes Mellitus
Publié: (2011)

Russian Association of Endocrinologists reports commencement of Amaril clinical use
par: Editorial team Diabetes Mellitus
Publié: (2012)

Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
par: Editorial team Diabetes Mellitus
Publié: (2011)

Russian Association of Endocrinologists reports commencement of Glucophage XR clinical use
par: Editorial team Diabetes Mellitus
Publié: (2011)

Anniversary of Russian association of endocrinologists
par: Natalya Pavlovna Makolina
Publié: (2015)

Russian Association of Endocrinologists expert consensus document on initiation and intensification of antyhyperglycaemic therapyin type 2 diabetes mellitus
par: Ivan Ivanovich Dedov, et autres
Publié: (2011)

New prospects in the treatment of diabetes mellitus
par: Minara Shamkhalovna Shamkhalova, et autres
Publié: (2012)

Initiation and intensification of antihyperglycemic therapy in type 2 diabetes mellitus: Update of Russian Association of Endocrinologists expert consensus document (2015)
par: Ivan Ivanovich Dedov, et autres
Publié: (2015)

Expert committee on introduction of incretin-based therapy in Russia: advance and failure
par: Editorial team Diabetes Mellitus
Publié: (2012)

The new drug saxagliptin is now registrated in Russia
par: Editorial team Diabetes Mellitus
Publié: (2010)

Resolution on V Russian congress of endocrinologists
par: Editorial team Diabetes Mellitus
Publié: (2006)

News from Russian association of endocrinologists
par: Editorial team Diabetes Mellitus
Publié: (2007)

Sections of the Russian association of endocrinologists and their responsible executives
par: Editorial team Diabetes Mellitus
Publié: (2007)

Russian association of endocrinologists departments and their responsible executives
par: Editorial team Diabetes Mellitus
Publié: (2006)

List of executive managers of the Russian Association of Endocrinologists
par: Editorial team Diabetes Mellitus
Publié: (2007)

List of executive managers of Russian association of endocrinologists
par: Editorial team Diabetes Mellitus
Publié: (2006)

Urate-lowering effects of dipeptidyl peptidase-4 inhibitors
par: Taras S. Panevin, et autres
Publié: (2020)

In memory of Professor Sagdulla A. Abusuev
par: editorial board Diabetes mellitus journal
Publié: (2017)

Rannyaya kombinirovannaya terapiya pri sakharnom diabete 2 tipa
par: Alexander Sergeevich Ametov, et autres
Publié: (2011)

Clinical implementetion of vildagliptin: data from recent studies comparing incretin-based medications
par: Elena Valer'evna Biryukova
Publié: (2014)

Efficacious and safe management of type 2 diabetes mellitus using DPP-4 inhibitors
par: Alexander Sergeevich Ametov, et autres
Publié: (2010)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
par: Marina Vladimirovna Shestakova
Publié: (2010)

Effectiveness prediction of Evogliptin treatment in type 2 diabetes mellitus in russian-korean population
par: Anna A. Mosikian, et autres
Publié: (2018)

XXV (88) Session of Russian Academy of Medical Sciences General Meeting, 7-9 December 2011, Moscow
par: Editorial team Diabetes Mellitus
Publié: (2011)

Type 2 diabetes mellitus in elderly patients treated with endocrinologists in clinical practice
par: Elena V. Biryukova
Publié: (2019)

Actual ambulatory care in patients with type 2 diabetes mellitus in Russian Federation according to open label prospectiveobservational study DIA-CONTROL
par: Marina Vladimirovna Shestakova
Publié: (2011)

Heart failure in diabetes: effects of anti-hyperglycemic drug therapy
par: Gagik R. Galstyan, et autres
Publié: (2016)

Vildagliptin: the first innovative DDP-4 inhibitor
par: Edvin Villkhauer
Publié: (2010)

Russian congress "Diabetes and Kindey"
par: Editorial team Diabetes Mellitus
Publié: (2008)

News of the Russian diabetes association
par: Editorial team Diabetes Mellitus
Publié: (2003)

Russian congress "Diabetes and Kidneys"
par: Editorial team Diabetes Mellitus
Publié: (2009)

Russian science conference "Diabetes and Kidney"
par: Editorial team Diabetes Mellitus
Publié: (2008)

News from Russian association endocrinology
par: Editorial team Diabetes Mellitus
Publié: (2006)

News from IV Russian Diabetology congress
par: Editorial team Diabetes Mellitus
Publié: (2008)

Initial investigation of efficacy and safety of a new dipeptidyl peptidase-4 inhibitor, gosogliptin, for type 2 diabetes in Russia
par: Lyudmila Viktorovna Nedosugova, et autres
Publié: (2014)

Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
par: Yury Ivanovich Suntsov
Publié: (2012)

Vildagliptin and its role in the treatment of diabetes mellitus
par: Yury Shavkatovich Khalimov
Publié: (2010)

5 Russian Diabetology Congress on May 23-26, 2010, Moscow
par: Editorial team Diabetes Mellitus
Publié: (2010)